Magnesium Myristate

Magnesium myristate is the magnesium salt of myristic acid, a saturated C14 fatty acid, primarily used as an excipient and emulsifier in cosmetic and pharmaceutical formulations. No peer-reviewed clinical trials support its use as an oral supplement for health benefits, distinguishing it sharply from bioavailable magnesium forms such as magnesium glycinate or magnesium citrate.

Origin & History

Magnesium myristate is the magnesium salt of myristic acid (tetradecanoic acid), with the chemical formula C₁₄H₃₀MgO₂. It is produced through the reaction of myristic acid—derived from sources like coconut oil or palm kernel oil—with magnesium hydroxide or magnesium carbonate in a controlled environment. This compound belongs to the class of long-chain fatty acids, specifically fatty acid salts with an aliphatic tail containing 14 carbon atoms.

Historical & Cultural Context

No information regarding historical use in traditional medicine systems is provided in the available research. Magnesium myristate appears to be a modern synthetic ingredient developed for cosmetic and industrial applications rather than a traditional medicinal substance.

Health Benefits

• No clinical health benefits documented - the available research contains no peer-reviewed clinical trials or therapeutic studies
• Limited to cosmetic applications - current evidence only supports use as an emulsifier and thickening agent in topical formulations
• No biomedical efficacy data - absence of RCTs, meta-analyses, or clinical evidence for any health claims
• Potential magnesium supplementation - theoretical benefit as a magnesium source, but no bioavailability or absorption data available
• Topical tolerance - considered safe for cosmetic use with rare allergic reactions, though this is not a health benefit per se

How It Works

Magnesium myristate functions through the ionic dissociation of the magnesium salt of myristic acid (tetradecanoic acid), where the fatty acid component interacts with lipid bilayers to provide emulsifying and film-forming properties in topical matrices. Unlike bioactive magnesium compounds, there is no established mechanism by which orally administered magnesium myristate activates NMDA receptors, ATP-dependent enzymes, or magnesium-dependent cofactor pathways at therapeutically relevant concentrations. The myristic acid moiety, if absorbed, would enter beta-oxidation or be incorporated into membrane phospholipids, but no clinical pharmacokinetic data confirm meaningful magnesium bioavailability from this salt form.

Scientific Research

The research dossier contains no peer-reviewed clinical trials, randomized controlled trials (RCTs), meta-analyses, or PubMed PMIDs evaluating magnesium myristate for therapeutic use in humans. The available sources focus exclusively on its cosmetic and industrial applications rather than clinical efficacy or safety studies in biomedical contexts.

Clinical Summary

As of current literature, there are zero published peer-reviewed randomized controlled trials, observational studies, or pharmacokinetic studies evaluating magnesium myristate as an oral supplement in human subjects. All documented applications appear exclusively in cosmetic science literature, where it is studied as a thickening agent and emulsifier in topical formulations rather than as a therapeutic compound. No quantified outcomes for serum magnesium elevation, muscle function, cardiovascular markers, or any biomedical endpoint have been reported. The complete absence of clinical trial data means no evidence-based dosage, efficacy claim, or therapeutic indication can be responsibly assigned to this compound.

Nutritional Profile

Magnesium Myristate is a magnesium salt of myristic acid (tetradecanoic acid), a 14-carbon saturated fatty acid. As a cosmetic/industrial compound rather than a dietary ingredient, its nutritional profile is highly limited. Molecular composition: approximately 7-8% elemental magnesium by molecular weight (Mg: ~24.3 g/mol within molecular weight of ~535 g/mol for the dimagnesium salt form). Fatty acid component: myristic acid chains (C14:0 saturated), constituting approximately 90%+ of molecular mass. Macronutrient classification: falls under lipid/fatty acid category due to myristate chains, but is not a dietary fat source in conventional use. Micronutrient relevance: theoretical magnesium content exists structurally, but bioavailability via topical or ingested routes is not clinically established; transdermal magnesium absorption from cosmetic-grade compounds is considered negligible to minimal based on current dermal absorption research. No fiber, protein, carbohydrate, or vitamin content. No documented bioactive phytochemical compounds. Caloric contribution: not established or applicable in cosmetic context. If incidentally ingested in trace cosmetic amounts, myristic acid is a known dietary saturated fatty acid found naturally in coconut oil (~18%) and palm kernel oil (~16%), but quantities from cosmetic exposure are nutritionally insignificant.

Preparation & Dosage

No clinically studied dosage ranges for magnesium myristate are documented in the available research. The only usage reference is a 'highest usage in residency products' of 0.256, which relates to cosmetic formulations rather than clinical dosing. Without clinical trial data, no evidence-based dosage recommendations can be provided. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Not applicable - no synergistic ingredients identified due to lack of clinical research

Safety & Interactions

Because no human clinical trials exist for oral magnesium myristate supplementation, a formal safety profile including dose-response relationships and adverse event frequencies has not been established. Topical use in cosmetics is generally considered safe at approved concentrations per regulatory bodies such as the EU Cosmetics Regulation, but this does not extrapolate to oral or systemic safety data. Potential interactions with medications that depend on magnesium homeostasis—such as digoxin, fluoroquinolone antibiotics, or bisphosphonates—cannot be assessed due to the lack of bioavailability data. Pregnant or breastfeeding individuals should avoid supplemental use given the complete absence of reproductive safety studies.